Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 16, 2024
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapyRoni Nitecki Wilke, Jinsong Liu, Shannon Neville Westin, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2023
MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?Roni Nitecki, Pedro T Ramirez, Pavel Dundr, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 1, 2023
Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative StudyErica M Bednar, J Alejandro Rauh-Hain, Jose J Garcia, et al.Obstetrics and Gynecology|May 6, 2021
Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian CancerRoni Nitecki, Mark A Clapp, Shuangshuang Fu, et al.American Journal of Obstetrics and Gynecology|June 20, 2026
International Trends in Concurrent Hysterectomy at Risk-Reducing Surgery in BRCA1/2 pathogenic variant carriers: A mixed-methods studyTamar A Gootzen, Barbara M Norquist, Roni Nitecki Wilke, et al.Obstetrics and Gynecology|October 8, 2021
Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical CancerRoni Nitecki, Jessica Floyd, Kelly Lamiman, et al.Familial Cancer|October 7, 2022
Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?Ryan Matthew Kahn, Muhammad Danyal Ahsan, Eloise Chapman-Davis, et al.American Journal of Obstetrics and Gynecology|June 18, 2025
Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II studyTamar A Gootzen, Miranda P Steenbeek, Marleen M H J van Gelder, et al.Cancer|October 28, 2022
What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testingMelissa K Frey, Muhammad Danyal Ahsan, Nora Badiner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-AnalysisMelissa K Frey, Muhammad Danyal Ahsan, Hannah Bergeron, et al.Pageof 8